Temporal cortex hypermetabolism in Down syndrome prior to the onset of dementia
暂无分享,去创建一个
Melina R. Uncapher | C. Cotman | R. Haier | N. White | M. Alkire | M. Uncapher | E. Head | I. Lott | R J Haier | M T Alkire | N S White | M R Uncapher | E Head | I T Lott | C W Cotman
[1] Mark S. Cohen,et al. Patterns of brain activation in people at risk for Alzheimer's disease. , 2000, The New England journal of medicine.
[2] M. Bobinski,et al. Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories , 1997, Neurobiology of Aging.
[3] C. Grady,et al. Down's syndrome in adults: brain metabolism. , 1983, Science.
[4] G. Alexander,et al. Declining brain activity in cognitively normal apolipoprotein E ɛ4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[5] N. Schupf,et al. Prevalence of dementia in adults with and without Down syndrome. , 1996, American journal of mental retardation : AJMR.
[6] N. Cairns,et al. Increased glyceraldehyde 3-phosphate dehydrogenase levels in the brain of patients with Down's syndrome , 1999, Neuroscience Letters.
[7] S. Deb,et al. Comparison of rating scales for the diagnosis of dementia in adults with Down's syndrome. , 2001, Journal of intellectual disability research : JIDR.
[8] N. Foster,et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.
[9] A. Huxley,et al. The dementia scale for Down's syndrome. , 2000, Journal of intellectual disability research : JIDR.
[10] Karl J. Friston,et al. Statistical parametric maps in functional imaging: A general linear approach , 1994 .
[11] N. Cairns,et al. Impaired brain glucose metabolism in patients with Down syndrome. , 1999, Journal of neural transmission. Supplementum.
[12] H. Evenhuis,et al. Further evaluation of the Dementia Questionnaire for Persons with Mental Retardation (DMR). , 1996, Journal of intellectual disability research : JIDR.
[13] M. Buchsbaum,et al. Cortical glucose metabolic rate correlates of abstract reasoning and attention studied with positron emission tomography , 1988 .
[14] Richard J. Haier,et al. Brain size and cerebral glucose metabolic rate in nonspecific mental retardation and down syndrome , 1995 .
[15] C. Cotman,et al. Parallel Compensatory and Pathological Events Associated with Tau Pathology in Middle Aged Individuals with Down Syndrome , 2003, Journal of neuropathology and experimental neurology.
[16] P Pietrini,et al. Brain cognition and metabolism in Down syndrome adults in association with development of dementia , 1996, Neuroreport.
[17] A. Smith,et al. Imaging the progression of Alzheimer pathology through the brain , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[18] N L Foster,et al. Discordance between Traditional Pathologic and Energy Metabolic Changes in Very Early Alzheimer's Disease: Pathophysiological Implications , 1999, Annals of the New York Academy of Sciences.
[19] K. Wisniewski,et al. Normal ageing in adults with Down's syndrome: a longitudinal study. , 1996, Journal of intellectual disability research : JIDR.
[20] G. Alexander,et al. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies. , 2002, The American journal of psychiatry.
[21] C Oliver,et al. Down's Syndrome and Alzheimer's disease: a review , 1986, Psychological Medicine.
[22] F. Fazio,et al. Impairment of Neocortical Metabolism Predicts Progression in Alzheimer’s Disease , 1999, Dementia and Geriatric Cognitive Disorders.
[23] P. Bendel,et al. Altered brain glucose metabolism in transgenic-PFKL mice with elevated l-phosphofructokinase: in vivo NMR studies , 1998, Brain Research.
[24] M. Mesulam. Neuroplasticity Failure in Alzheimer's Disease Bridging the Gap between Plaques and Tangles , 1999, Neuron.
[25] J V Haxby,et al. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia. , 1997, The American journal of psychiatry.
[26] H. Wiśniewski,et al. Alzheimer's disease in Down's syndrome , 1985, Neurology.
[27] J. Haxby,et al. Regional Cerebral Glucose Metabolism is Normal in Young Adults with down Syndrome , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[28] M. Bobinski,et al. Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET) , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[29] Karl J. Friston,et al. Cognitive Conjunction: A New Approach to Brain Activation Experiments , 1997, NeuroImage.
[30] R. S. Williams,et al. A prospective study of Alzheimer disease in Down syndrome. , 1989, Archives of neurology.
[31] E. Head,et al. Down syndrome and Alzheimer's disease: a link between development and aging. , 2001, Mental retardation and developmental disabilities research reviews.
[32] J. Talairach,et al. Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System: An Approach to Cerebral Imaging , 1988 .
[33] Nick C Fox,et al. Mapping the evolution of regional atrophy in Alzheimer's disease: Unbiased analysis of fluid-registered serial MRI , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[34] N. Cutler. Cerebral metabolism as measured with positron emission tomography (PET) and [18F] 2-deoxy-d-glucose: Healthy aging Alzheimer's disease and down syndrome , 1986, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[35] S. Black,et al. Evidence from Functional Neuroimaging of a Compensatory Prefrontal Network in Alzheimer's Disease , 2003, The Journal of Neuroscience.
[36] Nick C Fox,et al. Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images , 2001, The Lancet.
[37] J. Mazziotta,et al. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[38] S. Thibodeau,et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. , 1996, The New England journal of medicine.
[39] G. Alexander,et al. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. , 2001, JAMA.
[40] Nathan S White,et al. A voxel-based morphometric study of nondemented adults with Down Syndrome , 2003, NeuroImage.